The factors to look for in defensives

T.Rowe Price Randal Jenneke

1 July 2022
| By Laura Dew |
image
image
expand image

There are two stocks in the healthcare and infrastructure space which can help investors gain defensiveness in their portfolio, according to T.Rowe Price.

The companies that would be best able to manage through this period will likely be companies with strong pricing power, differentiated products, good industry structure and defensive volumes.

This included Resmed in the healthcare space and Transurban in the infrastructure sector.

Randal Jenneke, head of Australian equities at T. Rowe Price, said: “Resmed for example has a large underpenetrated market, and despite various input and logistics cost pressures, has been able to pass through price increases given their dominant market share and current lack of reputable competition.

“In infrastructure, Transurban for example has built-in price increases for its contracts. The nature of its cost structure brings high EBIT margins and margin stability. Anecdotally, you know the cost of tolls are rising when every second taxi driver makes a point or two about it.”

Shares in Resmed were down 14.5% since the start of the year and 5% over one year to 30 June while Transurban was up 4% since the start of the year and 0.4% over one year.

Read more about:

AUTHOR

Recommended for you

sub-bgsidebar subscription

Never miss the latest news and developments in wealth management industry

MARKET INSIGHTS

Completely agree Peter. The definition of 'significant change is circumstances relevant to the scope of the advice' is s...

1 month 2 weeks ago

This verdict highlights something deeply wrong and rotten at the heart of the FSCP. We are witnessing a heavy-handed, op...

1 month 3 weeks ago

Interesting. Would be good to know the details of the StrategyOne deal....

1 month 3 weeks ago

SuperRatings has shared the median estimated return for balanced superannuation funds for the calendar year 2024, finding the year achieved “strong and consistent positiv...

1 week 2 days ago

Six of the seven listed financial advice licensees have reported positive share price growth in 2024, with AMP and Insignia successfully reversing earlier losses. ...

4 weeks ago

Original bidder Bain Capital, which saw its first offer rejected in December, has returned with a revised bid for Insignia Financial....

2 days 8 hours ago

TOP PERFORMING FUNDS